@PIH, @MSF & @IRDglobal. A new partnership to change MDR-TB treatments around the world.

Joined June 2014
122 Photos and videos
Pinned Tweet
13 Nov 2024
Replying to @endTB
The endTB-Q clinical trial results represent a major advancement in the treatment of pre-XDR-TB. Read more here 👉bit.ly/endTBQresults @MSFsci @PIH @IRDGlobal @UNITAID #TB
5
9
971
13 Nov 2024
MAJOR NEWS: the endTB-Q clinical trial results are in! They were just presented at the #UnionConf, in Bali. Read the full press release here>>bit.ly/endTBQresults @MSFsci @PIH @IRDGlobal @UNITAID
2
9
13
1,238
14 Nov 2024
Important conclusions transpire from the results of the endTB-Q clinical trial. Read more here >> bit.ly/endTBQresults @MSFsci @PIH @IRDGlobal @UNITAID #TB #UnionConf
1
4
272
13 Nov 2024
The endTB-Q clinical trial results represent a major advancement in the treatment of pre-XDR-TB. Read more here 👉bit.ly/endTBQresults @MSFsci @PIH @IRDGlobal @UNITAID #TB
5
9
971
12 Nov 2024
Reminder: the presentation of the endTB-Q clinical trial results is happening tomorrow at the #UnionConf in Bali! More here👉bit.ly/endTB-Q. And stay tuned for details about the results of this groundbreaking trial! @MSFsci @PIH @IRDGlobal @UNITAID

3
6
368
24 Oct 2024
📢The results of the endTB-Q clinical trial, which assesses the safety and efficacy of a new and shorter regimen for the treatment of pre-XDR-TB, will be presented for the first time at the #UnionConf in Bali on Nov 13.👉bit.ly/endTB-Q @MSFsci @PIH @IRDGlobal @UNITAID

7
13
1,114
20 Aug 2024
📢 Breaking news: in a rapid communication, the WHO recommended 3 new, shorter, more tolerable regimens for MDR/RR-TB, which were studied in the endTB clinical trial! More details 👉bit.ly/4fUAsPS @MSFsci @PIH @IRDGlobal @UNITAID
10
38
25,459
25 Jul 2024
The endTB consortium partners are happy to report that the last visit for the last study participant in the endTB-Q trial was completed on 22 July! Read more: bit.ly/3Sm1oy0 @MSFsci @PIH @IRDGlobal @UNITAID
1
7
14
4,168
20 May 2024
🌟Join us on May 23, for #EpicentreScientificDay! Maelenn Gouillou, Biostatistician of the endTB project, will present findings on drug-resistant tuberculosis subgroups from the #endTB clinical trial. Don't miss it at 2:15pm at Salons de l'Aveyron in Paris. More info here👇🏾
📢 D-1 month before the Scientific Day! Ready to dive in? TB experts will be on hand to discuss DIAGNOSIS and TREATMENT, highlighting the challenges and solutions for the most vulnerable populations, in particular, children! Registration 👉🏾 epicentre.msf.org/en/scienti…
2
6
404
30 Apr 2024
🌟 Exciting news! Today at #ESCMIDGlobal2024, Dr. Lorenzo Guglielmetti, Director of the #endTB project, will be presenting a groundbreaking comparison of efficacy and safety between experimental regimens for MDR-TB from the endTB clinical trial (Hall H, 13:30-15:30).
30 Apr 2024
Ready for day 4 of #ESCMIDGlobal2024? While it is the final day, the fun is not over yet. We have plenty of symposiums, sessions and talks lined up. Whether you're joining onsite or remotely, tell us what is on your agenda today? Thank you for you the incredible turnout!
2
255
The @EndTB trial results increase patient-centred treatment options for RR/MDR-TB with three shortened, all-oral, noninferior regimens to a current well-performing standard of care. #MSFSciDaysSA2024 More details 👉msfsa.me/3vZYMh9

17 Apr 2024
Check out this interesting session on "Improving treatment of multidrug-resistant #TB" by Dr Kunda K. Mikanda at #MSFSciDay. He talks about the results from the endTB clinical trial Exciting opportunity to listen👉 bit.ly/3U07J1Z
3
4
557
16 Apr 2024
Save the date! 🚀 The MSF Scientific Days Southern Africa 2024 are starting tomorrow, Wed. April 17. We thank Dr. Kunda Mikanda, Principal Investigator of the endTB Clinical Trials site in Lesotho, who will present the results of the trial on improving the treatment of MDR-TB.
The MSF in Eswatini team is eagerly looking forward to the forthcoming MSF Scientific Days Southern Africa 2024 event, scheduled for April 17, 2024. This full-day event will be an opportunity for us to disseminate knowledge on various topics such as sexual health, tuberculosis,
1
185
endTB retweeted
20 Mar 2024
Joining hands for #WTBDay 2024, the endTB trial community met at IRD’s Community Dissemination Event. They celebrated their contribution in advancing knowledge for the treatment of MDR-TB. @PIH @MSF @UNITAID #irdglobal #tuberculosis 1/2.
1
7
11
1,055
22 Mar 2024
On this #WorldTBDay24 , join #endTB in celebrating last year’s achievements in the fight against multidrug-resistant #tuberculosis. Check out our latest news and results: endtb.org/news-stories and endtb.org/endtb-clinical-tri… @MSF_france @IRDGlobal @PIH @UNITAID @UCSF
9
20
886
18 Nov 2023
.@IRDGlobal @MSF @PIH , and funder @UNITAID would like thank all those who attended the endTB clinical trial results presentations at the #UnionConf this week! Safe travels home and stay tuned!
5
29
2,966
17 Nov 2023
Join us today at 6pm CET at the #UnionConf Community Connect session where researchers will share the #endTB trial results with communities! @MSFsci @IRDGlobal @PIH @UNITAID
10
558
15 Nov 2023
.@MSF @PIH @IRDGlobal, and funder @UNITAID are proud to announce that the endTB trial results are out! This landmark trial offers multiple new shortened, all-oral drug regimens to treat adults and children with #MDRTB. Read our press release and more here: bit.ly/3FXSOir

2
29
95
23,632
15 Nov 2023
The #endTB trial found 3 new drug regimens delivering similar efficacy & safety to conventional treatments while reducing treatment time by up to two-thirds.  The trial also adds a 4th regimen as an alternative for people who cannot tolerate some TB drugs. bit.ly/46a1n4g

1
3
18
518
15 Nov 2023
“Our results offer hope to those in dire need and underscore the urgency of continued research and innovation to address diseases that too often strike the most vulnerable among us", says Carole Mitnick, @PIH Director of Research for #endTB
3
17
1,344